Ralph Lauren Corp - Class A
Ralph Lauren Corporation is a global leader in the design, marketing and distribution of luxury lifestyle products in five categories: apparel, handbags, footwear & accessories, home, fragrances, and hospitality. For nearly 60 years, Ralph Lauren has sought to inspire the dream of a better life through authenticity and timeless style. Its reputation and distinctive image have been developed across a wide range of products, brands, distribution channels and international markets. The Company's brand names — which include Ralph Lauren, Ralph Lauren Collection, Ralph Lauren Purple Label, Double RL, Polo Ralph Lauren, Lauren Ralph Lauren, Polo Ralph Lauren Children and Chaps, among others — constitute one of the world's most widely recognized families of consumer brands.
Current Price
$329.24
+2.67%GoodMoat Value
$342.92
4.2% undervaluedRalph Lauren Corp - Class A (RL) Quality Analysis
RL Profitability
RL Growth
RL Financial Health
RL Quality & Fundamental Analysis
Ralph Lauren Corp - Class A (RL) is a Consumer Cyclical company in the Apparel Manufacturing industry, listed on NYSE. This quality analysis page evaluates Ralph Lauren Corp - Class A's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Ralph Lauren Corp - Class A has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 11.73% and a return on equity (ROE) of 35.48%. Return on assets (ROA) stands at 13.03%.
The debt-to-equity ratio is 1.02, with a current ratio of 1.78. Operating margin is 13.17%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Ralph Lauren Corp - Class A is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.